Sharon D. Yeatts
Medical University of South Carolina
91 Papers
174 Citations
Sharon D. Yeatts is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 26, co-authored 72 publications. Previous affiliations of Sharon D. Yeatts include University of Iowa.
Chat about Author
Papers
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
Gregory W. Albers,Michael P. Marks,Stephanie Kemp,Soren Christensen,Jenny P Tsai,Santiago Ortega-Gutierrez,Ryan A McTaggart,Michel T. Torbey,May Kim-Tenser,Thabele M Leslie-Mazwi,Amrou Sarraj,Scott E. Kasner,Sameer A. Ansari,Sharon D. Yeatts,Scott Hamilton,Michael Mlynash,Jeremy J Heit,Greg Zaharchuk,Sun Kim,Janice Carrozzella,Yuko Y. Palesch,Andrew M. Demchuk,Roland Bammer,Philip W. Lavori,Joseph P. Broderick,Maarten G Lansberg +25 more
TL;DR: Endovascular thrombectomy for ischemic stroke 6 to 16 hours after a patient was last known to be well plus standard medical therapy resulted in better functional outcomes than standard medical Therapy alone among patients with proximal middle‐cerebral‐artery or internal‐carotid‐arterY occlusion and a region of tissue that was ischeMIC but not yet infarcted.
Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
Joseph P. Broderick,Yuko Y. Palesch,Andrew M. Demchuk,Sharon D. Yeatts,Pooja Khatri,Michael D. Hill,Edward C. Jauch,Tudor G Jovin,Bernard Yan,Frank L. Silver,Ruediger von Kummer,Carlos A. Molina,Bart M. Demaerschalk,Ronald F. Budzik,Wayne M. Clark,Osama O. Zaidat,Tim W. Malisch,Mayank Goyal,Wouter J. Schonewille,Mikael Mazighi,Stefan T. Engelter,Craig S. Anderson,Judith Spilker,Janice Carrozzella,Karla J Ryckborst,L. Scott Janis,Renee H Martin,Lydia D. Foster,Thomas A. Tomsick +28 more
TL;DR: The trial showed similar safety outcomes and no significant difference in functional independence with endovascular therapy after intravenous t-PA, as compared with intravenoust-PA alone.
Very Early Administration of Progesterone for Acute Traumatic Brain Injury
David W. Wright,Sharon D. Yeatts,Robert Silbergleit,Yuko Y. Palesch,Vicki S. Hertzberg,Michael Frankel,Felicia C. Goldstein,Angela F. Caveney,Harriet Howlett-Smith,Erin M Bengelink,Geoffrey T. Manley,Lisa H. Merck,L. Scott Janis,William G. Barsan +13 more
TL;DR: This clinical trial did not show a benefit of progesterone over placebo in the improvement of outcomes in patients with acute TBI, and there were no significant differences in the other prespecified safety outcomes.
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial
Pooja Khatri,Sharon D. Yeatts,Mikael Mazighi,Joseph P. Broderick,David S Liebeskind,Andrew M. Demchuk,Pierre Amarenco,Janice Carrozzella,Judith Spilker,Lydia D. Foster,Mayank Goyal,Michael D. Hill,Yuko Y. Palesch,Edward C. Jauch,E. Clarke Haley,Achala Vagal,Thomas A. Tomsick +16 more
TL;DR: Delays in time to angiographic reperfusion lead to a decreased likelihood of good clinical outcome in patients after moderate to severe stroke, and this association was validated in a preplanned analysis of data from the IMS III trial.
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).
Gregory W. Albers,Maarten G Lansberg,Stephanie Kemp,Jenny P Tsai,Phil Lavori,Soren Christensen,Michael Mlynash,Sun Kim,Scott Hamilton,Sharon D. Yeatts,Yuko Y. Palesch,Roland Bammer,Joseph P. Broderick,Michael P. Marks +13 more
TL;DR: Among patients with large vessel anterior circulation occlusion who have a favorable imaging profile on computed tomography perfusion or magnetic resonance imaging, endovascular therapy with a Food and Drug Administration 510 K-cleared mechanical thrombectomy device reduces the degree of disability three months post stroke.
293